1464 related articles for article (PubMed ID: 30822098)
1. Sex Differences in Veterans Admitted to the Hospital for Chronic Obstructive Pulmonary Disease Exacerbation.
Bade BC; DeRycke EC; Ramsey C; Skanderson M; Crothers K; Haskell S; Bean-Mayberry B; Brandt C; Bastian LA; Akgün KM
Ann Am Thorac Soc; 2019 Jun; 16(6):707-714. PubMed ID: 30822098
[No Abstract] [Full Text] [Related]
2. Underutilization of Pulmonary Function Testing in Veterans Hospitalized for Chronic Obstructive Pulmonary Disease Exacerbation: Who are We Missing?
Bade BC; DeRycke EC; Skanderson M; Crothers K; Haskell S; Bean-Mayberry B; Cain HC; Brandt C; Bastian LA; Akgün KM
COPD; 2020 Feb; 17(1):15-21. PubMed ID: 31948267
[TBL] [Abstract][Full Text] [Related]
3. Depression Is Associated with Readmission for Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Iyer AS; Bhatt SP; Garner JJ; Wells JM; Trevor JL; Patel NM; Kirkpatrick d; Williams JC; Dransfield MT
Ann Am Thorac Soc; 2016 Feb; 13(2):197-203. PubMed ID: 26599286
[TBL] [Abstract][Full Text] [Related]
4. Reduction in Hospital Readmission Rates Among Medicare Beneficiaries With Chronic Obstructive Pulmonary Disease: A Real-world Outcomes Study of Nebulized Bronchodilators.
Keshishian A; Xie L; Dembek C; Yuce H
Clin Ther; 2019 Nov; 41(11):2283-2296. PubMed ID: 31630815
[TBL] [Abstract][Full Text] [Related]
5. Implementation of guideline-based therapy for chronic obstructive pulmonary disease: Differences between men and women veterans.
Rinne ST; Elwy AR; Liu CF; Wiener RS; Thayer L; Gerity A; Bastian LA
Chron Respir Dis; 2017 Nov; 14(4):385-391. PubMed ID: 28618875
[TBL] [Abstract][Full Text] [Related]
6. Role of Comorbidities in Treatment and Outcomes after Chronic Obstructive Pulmonary Disease Exacerbations.
Spece LJ; Epler EM; Donovan LM; Griffith MF; Collins MP; Feemster LC; Au DH
Ann Am Thorac Soc; 2018 Sep; 15(9):1033-1038. PubMed ID: 30079748
[TBL] [Abstract][Full Text] [Related]
7. Chronic Rhinitis Is a High-Risk Comorbidity for 30-Day Hospital Readmission of Patients with Asthma and Chronic Obstructive Pulmonary Disease.
Singh U; Wangia-Anderson V; Bernstein JA
J Allergy Clin Immunol Pract; 2019 Jan; 7(1):279-285.e6. PubMed ID: 30053594
[TBL] [Abstract][Full Text] [Related]
8. Quality of Care Delivered to Veterans with COPD Exacerbation and the Association with 30-Day Readmission and Death.
Spece LJ; Donovan LM; Griffith MF; Collins MP; Feemster LC; Au DH
COPD; 2018 Oct; 15(5):489-495. PubMed ID: 30822247
[TBL] [Abstract][Full Text] [Related]
9. Age-Related Differences in the Rate, Timing, and Diagnosis of 30-Day Readmissions in Hospitalized Adults With Asthma Exacerbation.
Hasegawa K; Gibo K; Tsugawa Y; Shimada YJ; Camargo CA
Chest; 2016 Apr; 149(4):1021-9. PubMed ID: 26836926
[TBL] [Abstract][Full Text] [Related]
10. Predictors of Appropriate Pharmacotherapy Management of COPD Exacerbations and Impact on 6-Month Readmission.
Tran M; Xiang P; Rascati KL; Stock EM; Godley PJ; Coleman A; Bogart MR; Stanford RH
J Manag Care Spec Pharm; 2016 Oct; 22(10):1186-93. PubMed ID: 27668567
[TBL] [Abstract][Full Text] [Related]
11. Association of Psychological Disorders With 30-Day Readmission Rates in Patients With COPD.
Singh G; Zhang W; Kuo YF; Sharma G
Chest; 2016 Apr; 149(4):905-15. PubMed ID: 26204260
[TBL] [Abstract][Full Text] [Related]
12. Long-acting bronchodilators with or without inhaled corticosteroids and 30-day readmission in patients hospitalized for COPD.
Bishwakarma R; Zhang W; Kuo YF; Sharma G
Int J Chron Obstruct Pulmon Dis; 2017; 12():477-486. PubMed ID: 28203071
[TBL] [Abstract][Full Text] [Related]
13. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
Blais L; Forget A; Ramachandran S
Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
[TBL] [Abstract][Full Text] [Related]
14. Hospitalization with acute exacerbation of chronic obstructive pulmonary disease and associated health resource utilization: a population-based Danish cohort study.
Johannesdottir SA; Christiansen CF; Johansen MB; Olsen M; Xu X; Parker JM; Molfino NA; Lash TL; Fryzek JP
J Med Econ; 2013 Jul; 16(7):897-906. PubMed ID: 23621504
[TBL] [Abstract][Full Text] [Related]
15. Identification of Asthma-COPD Overlap, Asthma, and Chronic Obstructive Pulmonary Disease Phenotypes in Patients with Airway Obstruction: Influence on Treatment Approach.
Romem A; Rokach A; Bohadana A; Babai P; Arish N; Azulai H; Glazer M; Izbicki G
Respiration; 2020; 99(1):35-42. PubMed ID: 31694032
[TBL] [Abstract][Full Text] [Related]
16. Suboptimal Inspiratory Flow Rates Are Associated with Chronic Obstructive Pulmonary Disease and All-Cause Readmissions.
Loh CH; Peters SP; Lovings TM; Ohar JA
Ann Am Thorac Soc; 2017 Aug; 14(8):1305-1311. PubMed ID: 28406710
[TBL] [Abstract][Full Text] [Related]
17. Gender differences in emergency department patients with chronic obstructive pulmonary disease exacerbation.
Cydulka RK; Rowe BH; Clark S; Emerman CL; Rimm AR; Camargo CA
Acad Emerg Med; 2005 Dec; 12(12):1173-9. PubMed ID: 16282511
[TBL] [Abstract][Full Text] [Related]
18. Impact of individualized care on readmissions after a hospitalization for acute exacerbation of COPD.
Adamson SL; Burns J; Camp PG; Sin DD; van Eeden SF
Int J Chron Obstruct Pulmon Dis; 2016; 11():61-71. PubMed ID: 26792986
[TBL] [Abstract][Full Text] [Related]
19. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
[TBL] [Abstract][Full Text] [Related]
20. Obesity and Severity of Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Goto T; Hirayama A; Faridi MK; Camargo CA; Hasegawa K
Ann Am Thorac Soc; 2018 Feb; 15(2):184-191. PubMed ID: 29053337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]